Recombinant Human Cathepsin B, CF

• Supplier: R&D Systems
• Catalog: 953-CY-010
• Category: Protein
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived, Arg18-Ile339 (pro) & Phe74-Ile339 (mature), both with a C-terminal 10-His tag
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: P07858
• Gene: CTSB

Product References

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells - Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells

Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat JL, Kanellopoulos J, Martin F, Rebe C, Apetoh L, Ghiringhelli F. Nat Med. 2013 Jan;19(1):57-64.

Fine-tuning nucleophosmin in macrophage differentiation and activation. - Fine-tuning nucleophosmin in macrophage differentiation and activation.

Guery L, Benikhlef N, Gautier T, Paul C, Jego G, Dufour E, Jacquel A, Cally R, Manoury B, Vanden Berghe T, Vandenabeele P, Droin N, Solary E. Blood. 2011 Oct 27;118(17):4694-704.

Design of protease-resistant myelin basic protein-derived peptides by cleavage - Design of protease-resistant myelin basic protein-derived peptides by cleavage

Burster T, Marin-Esteban V, Boehm BO, Dunn S, Rotzschke O, Falk K, Weber E, Verhelst SH, Kalbacher H, Driessen C. Biochem Pharmacol. 2007 Nov 15;74(10):1514-23. Epub 2007 Aug 2.

Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a - Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a

Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL. J Biol Chem. 2006 Jun 9;281(23):15893-9. Epub 2006 Mar 24.

Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. - Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.

Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. Genes Dev. 2006 Mar 1;20(5):543-56. Epub 2006 Feb 15.